Double Expression of Epidermal Growth Factor Receptor and N-Glycolyl GM3 Ganglioside in Human Malignant Tumors: A Study in Four Different Clinical Scenarios

Copyright: © 2017 Blanco R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Double Expression of Epidermal Growth Factor Receptor and N-Glycolyl GM3 Ganglioside in Human Malignant Tumors: A Study in Four Different Clinical Scenarios Rancés Blanco1*, Mercedes Cedeño1, Charles E Rengifo2, Damián Blanco3, Milagros Frometa1, Elizabeth Domínguez4, Mayra RamosSuzarte5, Adriana Carr6 and Enrique Rengifo1 1Center of Molecular Immunology, P.O. Box 16040, 216 St. and 15 Ave., Atabey, Playa, 11600 Havana, Cuba 2Department of Pathology, National Institute of Oncology and Radiobiology, 29 and F St., Vedado, Plaza de la Revolution, 10400 Havana, Cuba 3Department of Cell Biology and Tissues Banking, National Institute of Oncology and Radiobiology, 29 and F St., Vedado, Plaza de la Revolution, 10400 Havana, Cuba 4Laboratory of Biochemistry, Center of Molecular Immunology, P.O. Box 16040, 216 St. and 15 Ave., Atabey, Playa, 11600 Havana, Cuba 5Clinical Trials Direction, Center of Molecular Immunology, P.O. Box 16040, 216 St. and 15 Ave., Atabey, Playa, 11600 Havana, Cuba 6System Biology Direction, Center of Molecular Immunology, P.O. Box 16040, 216 St. and 15 Ave., Atabey, Playa, 11600 Havana, Cuba